CBDX (Curative Biosciences) Cyclically Adjusted PB Ratio: (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Curative Biosciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Curative Biosciences  (OTCPK:CBDX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Curative Biosciences Cyclically Adjusted PB Ratio Related Terms


Curative Biosciences Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Curative Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences Cyclically Adjusted PB Ratio Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBDX vs ACUR, CVLB, RDGL: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curative Biosciences Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Cyclically Adjusted PB Ratio falls into.



Curative Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Curative Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2018 is calculated as:

For example, Curative Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2018 was:

Adj_Book=Book Value per Share/CPI of Mar. 2018 (Change)*Current CPI (Mar. 2018)
=-0.036/249.5540*249.5540
=-0.036

Current CPI (Mar. 2018) = 249.5540.

Curative Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
200806 0.000 218.815 0.000
200809 0.000 218.783 0.000
200812 0.000 210.228 0.000
200903 0.000 212.709 0.000
200906 0.000 215.693 0.000
200909 -3.200 215.969 -3.698
200912 -6.000 215.949 -6.934
201003 -4.500 217.631 -5.160
201006 14.000 217.965 16.029
201009 -7.333 218.439 -8.378
201012 20.727 219.179 23.599
201103 24.000 223.467 26.802
201106 -10.700 225.722 -11.830
201109 15.833 226.889 17.415
201112 8.077 225.672 8.932
201203 -6.800 229.392 -7.398
201206 -84.217 229.478 -91.585
201209 -86.500 231.407 -93.283
201212 -68.433 229.601 -74.380
201303 -5.191 232.773 -5.565
201306 -3.154 233.504 -3.371
201309 -1.002 234.149 -1.068
201312 -0.001 233.049 -0.001
201403 -0.012 236.293 -0.013
201406 -0.067 238.343 -0.070
201409 -0.078 238.031 -0.082
201412 -0.085 234.812 -0.090
201503 -0.050 236.119 -0.053
201506 -0.062 238.638 -0.065
201509 -0.059 237.945 -0.062
201512 -0.036 236.525 -0.038
201603 -0.037 238.132 -0.039
201606 -0.040 241.018 -0.041
201609 -0.039 241.428 -0.040
201612 -0.039 241.432 -0.040
201703 -0.039 243.801 -0.040
201706 -0.040 244.955 -0.041
201709 -0.041 246.819 -0.041
201712 -0.043 246.524 -0.044
201803 -0.036 249.554 -0.036

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Curative Biosciences Business Description

Address 2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.